Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with extensive-stage small cell lung cancer

被引：0
|
作者：
Spigel, D. R.
Hainsworth, J. D.
Yardley, D. A.
Burris, H. A., III
Farley, C.
Zubkus, J.
Meng, C.
Murphy, P.
Saez, R.
Greco, F. A.
机构：
[1] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[2] Watson Clin Ctr Res, Lakeland, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18130
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Irinotecan, carboplatin, and imatinib in extensive stage small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network.
    Raefsky, EL
    Hainsworth, JD
    Rinaldi, D
    Schreeder, M
    Spigel, DR
    Burris, HA
    Yardley, DA
    Thompson, DS
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 691S - 691S
  • [22] Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer
    Socinski, Mark A.
    Weissman, Charles
    Hart, Lowell L.
    Beck, J. Thaddeus
    Choksi, Janak K.
    Hanson, John P.
    Prager, Diane
    Monberg, Matthew J.
    Ye, Zhishen
    Obasaju, Coleman K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) : 4840 - 4847
  • [23] DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer
    Bestvina, Christine M.
    Hara, Jared H. L.
    Karrison, Theodore
    Bowar, Benjamen
    Chin, Janet
    Garassino, Marina C.
    Pitroda, Sean P.
    Thawani, Rajat
    Yokes, Everett E.
    Gan, Gregory
    Zhang, Jun
    Baschnagel, Andrew M.
    Campbell, Toby C.
    Chmura, Steven
    Juloori, Aditya
    CLINICAL LUNG CANCER, 2024, 25 (08) : e448 - e452
  • [24] A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
    Byers, Lauren Averett
    Navarro, Alejandro
    Schaefer, Eric
    Johnson, Melissa
    Ozguroglu, Mustafa
    Han, Ji-Youn
    Bondarenko, Igor
    Cicin, Irfan
    Dragnev, Konstantin H.
    Abel, Adam
    Wang, Xuejing
    McNeely, Samuel
    Hynes, Scott
    Lin, Aimee Bence
    Forster, Martin
    CLINICAL LUNG CANCER, 2021, 22 (06) : 531 - 540
  • [25] Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer
    Lara, Primo N., Jr.
    Gandara, David R.
    Natale, Ronald B.
    CLINICAL LUNG CANCER, 2006, 7 (05) : 353 - 356
  • [26] Phase II Trial of Irinotecan plus Nedaplatin (INP) in Treating Patients with Extensive Stage Small Cell Lung Cancer
    Li, Chengguang
    Huang, Xin-En
    Li, Ying
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (02) : 487 - 490
  • [27] A PHASE-II TRIAL OF CARBOPLATIN IN UNTREATED PATIENTS WITH EXTENSIVE STAGE SMALL-CELL LUNG-CANCER
    PALLARES, C
    IZQUIERDO, MA
    PAREDES, A
    SAGARRA, AF
    DEANDRES, L
    LOPEZ, JJL
    CANCER, 1991, 68 (01) : 40 - 43
  • [28] Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer
    Langer, Corey J.
    Albert, Istvan
    Ross, Helen J.
    Kovacs, Peter
    Blakely, L. Johnetta
    Pajkos, Gabor
    Somfay, Attila
    Zatloukal, Petr
    Kazarnowicz, Andrzei
    Moezi, Mehdi M.
    Schreeder, Marshall T.
    Schnyder, Judy
    Ao-Baslock, Ada
    Pathak, Ashutosh K.
    Berger, Mark S.
    LUNG CANCER, 2014, 85 (03) : 420 - 428
  • [29] Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer
    Murata, Yasunori
    Hirose, Takashi
    Yamaoka, Toshimitsu
    Shirai, Takao
    Okuda, Kentaro
    Sugiyama, Tomohide
    Kusumoto, Sojiro
    Nakashima, Masanao
    Ohmori, Tohru
    Adachi, Mitsuru
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1336 - 1342
  • [30] Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Gadgeel, Shirish M.
    Pennell, Nathan A.
    Fidler, Mary Jo
    Halmos, Balazs
    Bonomi, Philip
    Stevenson, James
    Schneider, Bryan
    Sukari, Ammar
    Ventimiglia, Jaclyn
    Chen, Wei
    Galasso, Cathy
    Wozniak, Antoinette
    Boerner, Julie
    Kalemkerian, Gregory P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1393 - 1399
12345